SOFIVA GENOMICS Co (ROCO:6615) Total Liabilities : NT$123.7 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is SOFIVA GENOMICS Co Total Liabilities?

SOFIVA GENOMICS Co's Total Liabilities for the quarter that ended in Dec. 2024 was NT$123.7 Mil.

SOFIVA GENOMICS Co's quarterly Total Liabilities declined from Jun. 2024 (NT$135.13 Mil) to Sep. 2024 (NT$127.83 Mil) and declined from Sep. 2024 (NT$127.83 Mil) to Dec. 2024 (NT$123.68 Mil).

SOFIVA GENOMICS Co's annual Total Liabilities declined from Dec. 2022 (NT$180.24 Mil) to Dec. 2023 (NT$148.77 Mil) and declined from Dec. 2023 (NT$148.77 Mil) to Dec. 2024 (NT$123.68 Mil).

SOFIVA GENOMICS Co Total Liabilities Historical Data

The historical data trend for SOFIVA GENOMICS Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SOFIVA GENOMICS Co Total Liabilities Chart

SOFIVA GENOMICS Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

198.77

197.86

180.24

148.77

123.68

SOFIVA GENOMICS Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															148.77	139.44	135.13	127.83	123.68

SOFIVA GENOMICS Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

SOFIVA GENOMICS Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	83.457	+	(36.954	+	3.268
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	123.7

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	768.083	-	644.404
	=	123.7

SOFIVA GENOMICS Co's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	83.457	+	(36.954	+	3.268
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	123.7

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	768.083	-	644.404
	=	123.7

SOFIVA GENOMICS Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of SOFIVA GENOMICS Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

SOFIVA GENOMICS Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SOFIVA GENOMICS Co Ltd (ROCO:6615) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 66-1, Sec. 1, Chongqing S. Road, 4th Floor, Zhongzheng District, Taipei, TWN, 10043

Website

https://www.sofivagenomics.com.tw

SOFIVA GENOMICS Co Ltd provides medical diagnostic services. The services offered by the company include Prenatal, Reproductive, Cancer, Precision medicine, Newborn, and Rare Diseases. Its testing categories include Genetic, Biochemical, and Chromosome. The business items of Sofiva Group are pre-pregnancy, pre-natal and neonatal genetic testing and medical testing and other service income. Geographically, it generates the vast majority of its revenue from Taiwan.

SOFIVA GENOMICS Co Headlines

No Headlines